A deadly spillover: SARS-CoV-2 outbreak

Three Emerging Coronaviruses in Two Decades

(2020) Jeannette Guarner   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

A Systematic Review of Lopinavir Therapy for SARS Coronavirus and MERS Coronavirus–A Possible Reference for Coronavirus Disease‐19 Treatment Option

(2020) Tian‐Tian Yao et al.   JOURNAL OF MEDICAL VIROLOGY

Evolutionary history, potential intermediate animal host, and cross‐species analyses of SARS‐CoV‐2

(2020) Xingguang Li et al.   JOURNAL OF MEDICAL VIROLOGY

α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment

(2020) Linlin Zhang et al.   JOURNAL OF MEDICINAL CHEMISTRY

Therapeutic options for the 2019 novel coronavirus (2019-nCoV)

(2020) Guangdi Li et al.   NATURE REVIEWS DRUG DISCOVERY

A Novel Coronavirus from Patients with Pneumonia in China, 2019

(2020) Na Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Remdesivir as a possible therapeutic option for the COVID-19

(2020) Jaffar A. Al-Tawfiq et al.   Travel Medicine and Infectious Disease

Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses

(2020) Ning Wang et al.   Frontiers in Microbiology

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

(2020) Shuai Xia et al.   CELL RESEARCH

SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion

(2020) Xinling Wang et al.   Cellular & Molecular Immunology

Coronavirus disease 2019: the harms of exaggerated information and non-evidence-based measures

(2020) John P.A. Ioannidis   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

(2020) Zhenming Jin et al.   NATURE

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors

(2020) Linlin Zhang et al.   SCIENCE

Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes

(2018) Min-Han Lin et al.   ANTIVIRAL RESEARCH

Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission

(2018) David S Hui et al.   LANCET INFECTIOUS DISEASES

The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species

(2018) Daniela Niemeyer et al.   PLoS Pathogens

Discovery of unsymmetrical aromatic disulfides as novel inhibitors of SARS-CoV main protease: Chemical synthesis, biological evaluation, molecular docking and 3D-QSAR study

(2017) Li Wang et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

A review of candidate therapies for Middle East respiratory syndrome from a molecular perspective

(2017) Ali A. Rabaan et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

(2016) Travis K. Warren et al.   NATURE

p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLprovia E3 ubiquitin ligase RCHY1

(2016) Yue Ma-Lauer et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug Design

(2016) Fenghua Wang et al.   Scientific Reports

Coronavirus Genomics and Bioinformatics Analysis

(2010) Patrick C. Y. Woo et al.   Viruses-Basel